As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has ...
Zacks Investment Research on MSN
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...
Metsera said it expects the Pfizer deal to close promptly after a stockholder meeting scheduled for this coming Thursday ...
Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
Better still, if interest rates drop, as they're generally expected to over the coming year, the interest income you'll get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results